Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D Outcomes in Older Adults: Study Summary

Previous related pageVitamin D Outcomes in Older Adults: Full Evidence ReviewNext related pageVitamin D Outcomes in Older Adults: Full Evidence Review
Study at a glance

What question did the studies ask?

Does vitamin D reduce fractures, falls or infections, or improve function and other outcomes in older adults? Trials included women in residential care and generally healthier people living in the community. Some other trials included middle-aged as well as older adults.

What did they find?

One residential-care trial found fewer fractures with vitamin D3 plus calcium. Vitamin D3 alone did not demonstrate fewer fractures in a large community trial. Other trials did not demonstrate benefits on their main physical-function or infection outcomes. Higher doses did not clearly prevent falls, and some analyses raised concern about serious falls.

What does this mean?

Age alone does not describe nutrition, mobility or kidney function. Benefits from combined vitamin D and calcium cannot be assigned to vitamin D alone. An uncertain possible heart benefit and combined diabetes findings do not establish benefits for all older adults.

What are the limits?

Frail people and some severely deficient groups remain less well studied. Uncertainty does not prove they would benefit. Some reports described harms; a report of more deaths available only as an abstract could not be fully assessed. Research treatments are not individual treatment instructions.

Read the full article below ↓

Older adults differ in health, mobility, diet and living arrangements. This review compares vitamin D studies across those settings. It asks about fractures, falls, physical function, infections and outcomes including diabetes, without treating all older people as one group. Read the detailed assessment, Vitamin D Outcomes in Older Adults: Full Evidence Review.

What did the studies find?

An older trial in women living in residential care found fewer fractures with vitamin D3 combined with calcium. The benefit cannot be assigned to vitamin D alone. Many participants were much older than those in later community trials. For the skeletal background, see Vitamin D and Bone.

VITAL did not demonstrate fewer fractures with vitamin D3 alone in its generally healthier participants. STURDY did not establish a reduction in falls with higher doses compared with a group that also received vitamin D, at a lower amount. Some analyses raised concern about serious falls.

DO-HEALTH did not demonstrate vitamin D benefits on its main planned outcomes, including physical performance and infections. Its participants were generally active and healthy. A separate report, available here only as an abstract, in low-functioning older people also described no clear physical-function benefit, so low starting function does not guarantee a response. The muscle-function background is Vitamin D and Muscle Function.

D-Health’s estimate for heart and circulation problems suggested a possible modest benefit but remained uncertain. The analysis concerned one of many outcomes. It does not establish that monthly high doses prevent heart and circulation problems.

Diabetes-prevention studies had combined results suggesting some benefit, but they were not designed specifically for frail people in their eighties or nineties. One used an active vitamin D-like drug rather than nutritional vitamin D3.

Why do the settings matter?

Age alone does not describe nutrition, kidney function or fracture risk. A combined treatment in residential care is different from vitamin D alone in healthy community volunteers. Results from one cannot automatically replace results from the other. For the distinction between blood measurements and function, see Functional Vitamin D Status.

An infection outcome also does not measure every part of immune function. A blood marker or an ageing-related laboratory measure does not establish that the immune system has become younger.

What are the main limits?

Some frail and severely deficient groups remain less well studied. That uncertainty is not proof they would benefit. Some trials reported possible harms, and one report available here only as an abstract described more deaths. That report could not be fully assessed.

The evidence does not support one dose or blood target for every older adult. Research treatments describe the studies and should not replace individual clinical assessment.

Sources

Related reading

Physiology

Vitamin D in Older Adults

Explore how vitamin D participates in later-life physiology, supporting regulatory balance across skeletal, immune, metabolic, neuromuscular, and neuroendocrine systems.

Read more →

Original sources

Source

Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial

Published in Bischoff-Ferrari HA et al (2020).

Publication details

Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. Bischoff-Ferrari HA et al. 2020. JAMA. Volume 324(18); pages/article 1855-1868. DOI: 10.1001/jama.2020.16909.

Read more →
Source

Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial

Published in Costenbader KH et al (2024).

Publication details

Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. Costenbader KH et al. 2024. Arthritis & rheumatology (Hoboken, N.J.). Volume 76(6); pages/article 973-983. DOI: 10.1002/art.42811.

Read more →
Source

Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials

Published in Pittas AG et al (2023).

Publication details

Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Pittas AG et al. 2023. Annals of internal medicine. Volume 176(3); pages/article 355-363. DOI: 10.7326/m22-3018.

Read more →
Source

Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial

Published in Joseph P et al (2023).

Publication details

Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial. Joseph P et al. 2023. Nutrition, metabolism, and cardiovascular diseases : NMCD. Volume 33(2); pages/article 434-440. DOI: 10.1016/j.numecd.2022.11.001. Abstract-level background only; the complete principal paper was unavailable for appraisal.

Read more →
Source

Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial

Published in Houston DK et al (2023).

Publication details

Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial. Houston DK et al. 2023. The American journal of clinical nutrition. Volume 117(6); pages/article 1086-1095. DOI: 10.1016/j.ajcnut.2023.04.021. Abstract-level background only; the complete principal paper was unavailable for appraisal.

Read more →